D. W. Cockcroft and M. H. Gault, Prediction of Creatinine Clearance from Serum Creatinine, Nephron, vol.16, issue.1, pp.31-41, 1976.
DOI : 10.1159/000180580

A. S. Levey, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

A. S. Levey, A New Equation to Estimate Glomerular Filtration Rate, Annals of Internal Medicine, vol.150, issue.9, pp.604-612, 2009.
DOI : 10.7326/0003-4819-150-9-200905050-00006

S. Française-de-néphrologie, Évaluation de la fonction rénale et de la protéinurie pour le diagnostic de la maladie rénale chronique chez l'adulte. Recommandations pour la pratique clinique, Néphrologie Thérapeutique, vol.5, pp.302-305, 2009.

B. Stengel, C. Couchoud, and C. Helmer, Epidemiology of chronic kidney disease in France, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00173079

J. Coresh, B. C. Astor, T. Greene, G. Eknoyan, and A. S. Levey, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey, American Journal of Kidney Diseases, vol.41, issue.1, pp.1-12, 2003.
DOI : 10.1053/ajkd.2003.50007

J. Coresh, Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000, Journal of the American Society of Nephrology, vol.16, issue.1, pp.180-188, 1999.
DOI : 10.1681/ASN.2004070539

S. I. Hallan, International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk, Journal of the American Society of Nephrology, vol.17, issue.8, pp.2275-2284, 2006.
DOI : 10.1681/ASN.2005121273

P. Dequiedt, Équilibre hydro-électrolytique physiologie, physiopathologie et pratique clinique, Médecine sciences publications, 2011.

R. Somrani, Diététique et traitement conservateur de l'insuffisance rénale chronique de l'enfant

L. Berwert, D. Teta, and A. Zanchi, Insuffisance rénale chronique et médicaments antidiabétiques, 2007.

D. Godin, Réabsorption et sécrétion tubulaires, 2011.

L. I. Liaison-information-en-néphrologie, Vivre avec une maladie des reins, 2007.

B. Kestenbaum, Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease, Journal of the American Society of Nephrology, vol.16, issue.2, pp.520-528, 2005.
DOI : 10.1681/ASN.2004070602

F. Duranton, Normal and Pathologic Concentrations of Uremic Toxins, Journal of the American Society of Nephrology, vol.23, issue.7, pp.1258-1270, 2012.
DOI : 10.1681/ASN.2011121175

J. J. Sim, Association of plasma renin activity and aldosterone???renin ratio with prevalence of chronic kidney disease, Journal of Hypertension, vol.29, issue.11, pp.2226-2235, 2011.
DOI : 10.1097/HJH.0b013e32834bbc8a

G. Remuzzi, N. Perico, M. Macia, and P. Ruggenenti, The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease, Kidney International, vol.68, pp.57-65, 2005.
DOI : 10.1111/j.1523-1755.2005.09911.x

M. Lafage-proust, Physiopathologie de l'atteinte osseuse au cours de l'insuffisance rénale chronique, 2012.

J. Bacchetta, Parathormone et??maladie r??nale chronique, N??phrologie & Th??rapeutique, vol.3, issue.4, pp.133-138, 2007.
DOI : 10.1016/j.nephro.2007.04.003

R. Oprisiu, Ostéodystrophie rénale (1); diagnostic invasif et non invasif des variétés histopathologiques, Nephrologie, vol.21, pp.229-237, 2000.

A. Hossein-nezhad and M. F. Holick, Vitamin D for Health: A Global Perspective, Mayo Clinic Proceedings, vol.88, issue.7
DOI : 10.1016/j.mayocp.2013.05.011

J. Landrier, Vitamine D : sources, m??tabolisme et m??canismes d???action, OCL, vol.21, issue.3, p.302, 2014.
DOI : 10.1051/ocl/2014001

M. F. Holick, Vitamin D deficiency in 2010: Health benefits of vitamin D and sunlight: a D-bate, Nature Reviews Endocrinology, vol.92, issue.2
DOI : 10.1038/nrendo.2010.234

E. Murry, Actualités sur la vitamine D et nouvelles perspectives thérapeutiques, 2011.

G. L. Barbour, J. W. Coburn, E. Slatopolsky, A. W. Norman, and R. L. Horst, Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin D, New England Journal of Medicine, vol.305, issue.8, pp.440-443, 1981.
DOI : 10.1056/NEJM198108203050807

D. Pavlovic, D. Katicic, T. Gulin, and J. Josipovic, Vitamin D in the Patients with Chronic Kidney Disease: When, to Whom and in Which Form, Materia Socio Medica, vol.27, issue.2, pp.122-124, 2015.
DOI : 10.5455/msm.2015.27.122-124

S. Christakos, D. V. Ajibade, P. Dhawan, A. J. Fechner, and L. Mady, Vitamin D: Metabolism, Endocrinology and Metabolism Clinics of North America, vol.39, issue.2, pp.243-253, 2010.
DOI : 10.1016/j.ecl.2010.02.002

R. P. Heaney, R. L. Horst, D. M. Cullen, and L. A. Armas, Distribution and Status in the Body, Journal of the American College of Nutrition, vol.77, issue.3, pp.252-256, 2009.
DOI : 10.1080/07315724.2009.10719779

E. Catherinot, Les multiples facettes de la vitamine D, Revue des Maladies Respiratoires Actualit??s, vol.2, issue.5, pp.436-441, 2010.
DOI : 10.1016/S1877-1203(10)70115-4

B. D. Boyan, J. Chen, and Z. Schwartz, Mechanism of Pdia3-dependent 1??,25-dihydroxy vitamin D3 signaling in musculoskeletal cells, Steroids, vol.77, issue.10, pp.892-896, 2012.
DOI : 10.1016/j.steroids.2012.04.018

A. Martin, Apport nutrionnels conseillés pour la population Française, 2001.

A. Vitamine and D. , at <https://www.anses.fr/fr/content/vitamine-d> 48. Dietary reference intakes: calcium, vitamin D, 2011.

R. E. Laclair, Prevalence of Calcidiol Deficiency in CKD: A Cross-Sectional Study Across Latitudes in the United States, American Journal of Kidney Diseases, vol.45, issue.6, pp.1026-1033, 2005.
DOI : 10.1053/j.ajkd.2005.02.029

R. Mehrotra, Chronic kidney disease, hypovitaminosis D, and mortality in the United States, Kidney International, vol.76, issue.9, pp.977-983, 2009.
DOI : 10.1038/ki.2009.288

D. V. Barreto, Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.4, issue.6, pp.1128-1135, 2009.
DOI : 10.2215/CJN.00260109

I. Guessous, Comparisons of Serum Vitamin D Levels, Status, and Determinants in Populations With and Without Chronic Kidney Disease Not Requiring Renal Dialysis: A 24-Hour Urine Collection Population-Based Study, Journal of Renal Nutrition, vol.24, issue.5, pp.303-312, 2014.
DOI : 10.1053/j.jrn.2014.04.005

I. Guessous, Serum 25-Hydroxyvitamin D Level and Kidney Function Decline in a Swiss General Adult Population, Clinical Journal of the American Society of Nephrology, vol.10, issue.7, pp.1162-1169, 2015.
DOI : 10.2215/CJN.04960514

J. Cunningham and D. Zehnder, New Vitamin D analogs and changing therapeutic paradigms, Kidney International, vol.79, issue.7
DOI : 10.1038/ki.2010.387

G. Jean and C. Chazot, La vitamine D et l???insuffisance r??nale chronique??: les douze points essentiels, M??decine Nucl??aire, vol.39, issue.5, 2015.
DOI : 10.1016/j.mednuc.2015.05.002

J. Michaud, Reduced Hepatic Synthesis of Calcidiol in Uremia, Journal of the American Society of Nephrology, vol.21, issue.9, pp.1488-1497, 2010.
DOI : 10.1681/ASN.2009080815

A. Cupisti, Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report, International Journal of Nephrology and Renovascular Disease, pp.10-2147, 2015.
DOI : 10.2147/IJNRD.S90968

P. Ureña-torres, Association of Kidney Function, Vitamin D Deficiency, and Circulating Markers of Mineral and Bone Disorders in CKD, American Journal of Kidney Diseases, vol.58, issue.4, pp.544-553, 2011.
DOI : 10.1053/j.ajkd.2011.04.029

K. B. Jonsson, The role of fibroblast growth factor 23 in renal disease, Nephrology Dialysis Transplantation, vol.20, issue.3, pp.479-482, 2005.
DOI : 10.1093/ndt/gfh701

M. S. Razzaque and B. Lanske, The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis, Journal of Endocrinology, vol.194, issue.1, pp.1-10, 2007.
DOI : 10.1677/JOE-07-0095

M. Usatii, Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis, Kidney International, vol.72, issue.11, pp.1330-1335, 2007.
DOI : 10.1038/sj.ki.5002532

G. Glorieux and R. Vanholder, Blunted response to vitamin D in uremia, Kidney Int, vol.78, pp.182-185, 2001.

S. R. Patel, H. Q. Ke, R. Vanholder, R. J. Koenig, and C. H. Hsu, Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins., Journal of Clinical Investigation, vol.96, issue.1, pp.50-59, 1995.
DOI : 10.1172/JCI118061

M. Melamed, E. Michos, W. Post, and B. Astor, 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population, Archives of Internal Medicine, vol.168, issue.15, pp.1629-1637, 2008.
DOI : 10.1001/archinte.168.15.1629

S. Pilz, S. Iodice, A. Zittermann, W. B. Grant, and S. Gandini, Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies, American Journal of Kidney Diseases, vol.58, issue.3, pp.374-382, 2011.
DOI : 10.1053/j.ajkd.2011.03.020

T. Yoshizawa, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning, Nature Genetics, vol.90, issue.4, pp.391-396, 1997.
DOI : 10.1016/0092-8674(94)90274-7

P. Marie, Diff??renciation, fonction et contr??le de l???ost??oblaste, m??decine/sciences, vol.17, issue.12, 2001.
DOI : 10.1051/medsci/200117121252

L. Picault-thebault, Etat des lieux de l'hypovitaminose D en Indre et Loire en 2011 à partir des données de trois laboratoires : Analyse des prescriptions et des résultats, 2012.

P. H. Anderson, Vitamin D Depletion Induces RANKL-Mediated Osteoclastogenesis and Bone Loss in a Rodent Model, Journal of Bone and Mineral Research, vol.256, issue.11, pp.1789-1797, 2008.
DOI : 10.1359/jbmr.060714

N. Takahashi, N. Udagawa, and T. Suda, Vitamin D endocrine system and osteoclasts, BoneKEy Rep, vol.3, p.495, 2014.

H. A. Bischoff-ferrari, T. Dietrich, E. J. Orav, and B. Dawson-hughes, Positive association between 25-hydroxy vitamin d levels and bone mineral density: a population-based study of younger and older adults, The American Journal of Medicine, vol.116, issue.9, pp.634-639, 2004.
DOI : 10.1016/j.amjmed.2003.12.029

B. Tang, G. Eslick, C. Nawson, C. Smith, and A. Bensoussan, Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older : a meta-analysis

M. C. Chapuy, M. E. Arlot, P. D. Delmas, and P. J. Meunier, Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women, BMJ, vol.308, issue.6936, pp.1081-1082, 1994.
DOI : 10.1136/bmj.308.6936.1081

H. A. Bischoff-ferrari, A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention, New England Journal of Medicine, vol.367, issue.1, pp.40-49, 2012.
DOI : 10.1056/NEJMoa1109617

H. A. Bischoff-ferrari, Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials, BMJ, vol.339, issue.oct01 1, p.3692, 2009.
DOI : 10.1136/bmj.b3692

R. R. Kalyani, Vitamin D Treatment for the Prevention of Falls in Older Adults: Systematic Review and Meta-Analysis, Journal of the American Geriatrics Society, vol.93, issue.7, pp.1299-1310, 2010.
DOI : 10.1111/j.1532-5415.2010.02949.x

M. Freundlich, Suppression of renin???angiotensin gene expression in the kidney by paricalcitol, Kidney International, vol.74, issue.11, pp.1394-1402, 2008.
DOI : 10.1038/ki.2008.408

M. L. Melamed, 25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease, Journal of the American Society of Nephrology, vol.20, issue.12, pp.2631-2639, 2009.
DOI : 10.1681/ASN.2009030283

I. H. De-boer, Serum 25-Hydroxyvitamin D and Change in Estimated Glomerular Filtration Rate, Clinical Journal of the American Society of Nephrology, vol.6, issue.9, pp.2141-2149, 2011.
DOI : 10.2215/CJN.02640311

P. Ravani, Vitamin D levels and patient outcome in chronic kidney disease, Kidney International, vol.75, issue.1, pp.88-95, 2009.
DOI : 10.1038/ki.2008.501

N. Tanaci, Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study, Transplantation Proceedings, vol.35, issue.8, pp.2885-2887, 2003.
DOI : 10.1016/j.transproceed.2003.10.014

S. Sezer, M. Uyar, Z. Arat, F. N. Ozdemir, and M. Haberal, Potential Effects of 1,25-Dihydroxyvitamin D(3) in Renal Transplant Recipients, Transplantation Proceedings, vol.37, issue.7, pp.3109-3111, 2005.
DOI : 10.1016/j.transproceed.2005.07.026

M. Courbebaisse, J. Souberbielle, and E. Thervet, Potential Nonclassical Effects of Vitamin D in Transplant Recipients, Transplantation, vol.89, issue.2, pp.131-137, 2010.
DOI : 10.1097/TP.0b013e3181c6910f

F. Bienaimé, Vitamin D Status and Outcomes After Renal Transplantation, Journal of the American Society of Nephrology, vol.24, issue.5, pp.831-841, 2013.
DOI : 10.1681/ASN.2012060614

M. Courbebaisse, C. Cormier, D. Vitamine, and . Santé-cardiovasculaire, Vitamine D et sant?? cardiovasculaire, Cahiers de Nutrition et de Di??t??tique, vol.49, issue.6, pp.267-272, 2014.
DOI : 10.1016/j.cnd.2014.07.010

N. Chitalia, Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients, PLoS ONE, vol.163, issue.3, 2014.
DOI : 10.1371/journal.pone.0091363.s002

S. K. Kunutsor, T. A. Apekey, and M. Steur, Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants, European Journal of Epidemiology, vol.307, issue.7, pp.205-221, 2013.
DOI : 10.1007/s10654-013-9790-2

M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen, Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.4, pp.1633-1637, 2001.
DOI : 10.1210/jc.86.4.1633

M. D. Witham, M. A. Nadir, and A. D. Struthers, Effect of vitamin D on blood pressure: a systematic review and meta-analysis, Journal of Hypertension, vol.27, issue.10, pp.1948-1954, 2009.
DOI : 10.1097/HJH.0b013e32832f075b

A. G. Pittas, Systematic Review: Vitamin D and Cardiometabolic Outcomes, Annals of Internal Medicine, vol.152, issue.5
DOI : 10.7326/0003-4819-152-5-201003020-00009

R. Gaertner, D. Logeart, J. Michel, and J. Mercadier, Remodelage précoce du ventricule gauche après un accident coronarien aigu, MS Médecine Sci, vol.20, pp.643-650, 2004.

C. Cormier, M. Courbebaisse, E. Maury, E. Thervet, and J. Souberbielle, Influence de la vitamine D sur le risque cardiovasculaire, Journal des Maladies Vasculaires, vol.35, issue.4, pp.235-241, 2010.
DOI : 10.1016/j.jmv.2010.05.001

S. Pilz, A. Tomaschitz, C. Drechsler, J. M. Dekker, and W. März, Vitamin D deficiency and myocardial diseases, Molecular Nutrition & Food Research, vol.93, pp.1103-1113, 2010.
DOI : 10.1002/mnfr.200900474

B. Kestenbaum, Vitamin D, Parathyroid Hormone, and Cardiovascular Events Among Older Adults, Journal of the American College of Cardiology, vol.58, issue.14, pp.1433-1441, 2011.
DOI : 10.1016/j.jacc.2011.03.069

R. Thadhani, Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease, JAMA, vol.307, issue.7, pp.674-684, 2012.
DOI : 10.1001/jama.2012.120

R. S. Boxer, A Randomized Controlled Trial of High-Dose Vitamin D3 in Patients With Heart Failure, JACC: Heart Failure, vol.1, issue.1, pp.84-90, 2013.
DOI : 10.1016/j.jchf.2012.11.003

L. Wang, Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies, Circulation: Cardiovascular Quality and Outcomes, vol.5, issue.6, pp.819-829, 2012.
DOI : 10.1161/CIRCOUTCOMES.112.967604

S. Pilz, Vitamin D, cardiovascular disease and mortality, Clinical Endocrinology, vol.21, issue.Suppl. 2, pp.575-584, 2011.
DOI : 10.1111/j.1365-2265.2011.04147.x

E. Giovannucci, Y. Liu, B. W. Hollis, and E. Rimm, 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men<subtitle>A Prospective Study</subtitle>, Archives of Internal Medicine, vol.168, issue.11, pp.1174-1180, 2008.
DOI : 10.1001/archinte.168.11.1174

M. B. Elamin, Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.7, pp.1931-1942, 2011.
DOI : 10.1210/jc.2011-0398

. Fédération-international-du-diabète, Diabète et maladies rénales International Diabetes Federation at <http

R. Bland, Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets, J

J. A. Johnson, J. P. Grande, P. C. Roche, and R. Kumar, Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas, Am. J. Physiol, vol.267, pp.356-360, 1994.

B. Maestro, N. Dávila, M. C. Carranza, and C. Calle, Identification of a Vitamin D response element in the human insulin receptor gene promoter, The Journal of Steroid Biochemistry and Molecular Biology, vol.84, issue.2-3, pp.223-230, 2003.
DOI : 10.1016/S0960-0760(03)00032-3

U. Zeitz, Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor, The FASEB Journal, vol.17, pp.509-511, 2003.
DOI : 10.1096/fj.02-0424fje

J. Schlienger, F. Luca, and C. Griffon, D??ficit en vitamine D et risque de diab??te, M??decine des Maladies M??taboliques, vol.4, issue.5, pp.558-562, 2010.
DOI : 10.1016/S1957-2557(10)70122-X

A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-hughes, The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.6, pp.2017-2029, 2007.
DOI : 10.1210/jc.2007-0298

A. G. Pittas, Vitamin D and Calcium Intake in Relation to Type 2 Diabetes in Women, Diabetes Care, vol.29, issue.3, pp.650-656, 2006.
DOI : 10.2337/diacare.29.03.06.dc05-1961

E. Hyppönen and C. Power, Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort: The role of obesity, Diabetes Care, vol.29, issue.10, pp.2244-2246, 2006.
DOI : 10.2337/dc06-0946

J. Yu, Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice, J. Alzheimers Dis. JAD, vol.25, pp.295-307, 2011.

M. T. Mizwicki, 25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-? Phagocytosis and Inflammation in Alzheimer's Disease Patients, J, vol.1

M. O. Grimm, Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-?? Peptide Degradation in Alzheimer's Disease, Neurodegenerative Diseases, vol.13, issue.2-3, pp.75-81, 2014.
DOI : 10.1159/000355462

R. C. Rossom, Calcium and Vitamin D Supplementation and Cognitive Impairment in the Women's Health Initiative, Journal of the American Geriatrics Society, vol.53, issue.9, pp.2197-2205, 2012.
DOI : 10.1111/jgs.12032

M. P. Smith, A. Fletcher-turner, D. M. Yurek, and W. A. Cass, Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine, Neurochemical Research, vol.13, issue.Suppl 1, p.6
DOI : 10.1007/s11064-006-9048-4

E. Puchacz, W. E. Stumpf, E. K. Stachowiak, and M. K. Stachowiak, Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells, Molecular Brain Research, vol.36, issue.1, pp.193-196, 1996.
DOI : 10.1016/0169-328X(95)00314-I

D. Eyles, Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain, The Journal of Steroid Biochemistry and Molecular Biology, vol.103, issue.3-5
DOI : 10.1016/j.jsbmb.2006.12.096

URL : https://hal.archives-ouvertes.fr/hal-00320753

P. Millet, V. Landel, I. Virard, M. Morello, and F. Féron, R??les b??n??fiques de la vitamine D sur la neurod??g??n??rescence et les troubles mentaux, Cahiers de Nutrition et de Di??t??tique, vol.49, issue.6, pp.279-293, 2014.
DOI : 10.1016/j.cnd.2014.03.006

K. L. Munger, L. I. Levin, B. W. Hollis, N. S. Howard, and A. Ascherio, Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis, JAMA, vol.296, issue.23, pp.2832-2838, 2006.
DOI : 10.1001/jama.296.23.2832

R. Brent, Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study

E. M. Mowry, Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis, Ann. Neurol, vol.67, pp.618-624, 2010.

C. Pierrot-deseilligny, S. Rivaud-péchoux, P. Clerson, R. De-paz, and J. Souberbielle, Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation, Therapeutic Advances in Neurological Disorders, vol.5, issue.4, pp.187-198, 2012.
DOI : 10.1177/1756285612447090

P. T. Liu, Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response, Science, vol.311, issue.5768, pp.1770-1773, 2006.
DOI : 10.1126/science.1123933

A. F. Gombart, Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis, Clinical Infectious Diseases, vol.48, issue.4, pp.418-424, 2009.
DOI : 10.1086/596314

E. Giovannucci, Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men, JNCI Journal of the National Cancer Institute, vol.98, issue.7, pp.451-459, 2006.
DOI : 10.1093/jnci/djj101

J. Souberbielle, Actualit??s sur la vitamine D, Cahiers de Nutrition et de Di??t??tique, vol.48, issue.2, pp.63-74, 2013.
DOI : 10.1016/j.cnd.2013.01.001

C. F. Garland, SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY, The Lancet, vol.334, issue.8673
DOI : 10.1016/S0140-6736(89)91789-3

P. Engel, Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.9
DOI : 10.1158/1055-9965.EPI-10-0264

M. J. Bolland, A. Grey, G. D. Gamble, and I. Reid, Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set, American Journal of Clinical Nutrition, vol.94, issue.4
DOI : 10.3945/ajcn.111.015032

H. A. Bischoff-ferrari, E. Giovannucci, W. C. Willett, T. Dietrich, and B. Dawson-hughes, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am. J. Clin. Nutr, vol.84, pp.18-28, 2006.

L. Tripkovic, Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis, American Journal of Clinical Nutrition, vol.95, issue.6, pp.1357-1364, 2012.
DOI : 10.3945/ajcn.111.031070

N. Firmin, P. Lamy, G. Romieu, and W. Jacot, Vitamine D et cancer du sein: physiopathologie, implications biologiques et cliniques, Bull. Cancer (Paris), vol.101, pp.266-282, 2014.

L. Steingrimsdottir, O. Gunnarsson, O. S. Indridason, L. Franzson, and G. Sigurdsson, Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake, JAMA, vol.294, issue.18, pp.2336-2341, 2005.
DOI : 10.1001/jama.294.18.2336

J. Souberbielle, Rapport de la HAS sur les dosages de vitamine D??: ne passons pas d???une situation extr??me ?? une autre situation tout aussi extr??me, La Presse M??dicale, vol.43, issue.1, pp.5-8, 2014.
DOI : 10.1016/j.lpm.2013.12.005

J. , G. Fouque, D. Souberbielle, and J. , Pourquoi faut-il doser la vitamine D chez les patients insuffisants rénaux chroniques

M. F. Holick, D. Vitamin, and . Deficiency, Vitamin D Deficiency, New England Journal of Medicine, vol.357, issue.3, pp.266-281, 2007.
DOI : 10.1056/NEJMra070553

T. Ernandez and C. Stroerlann-chopard, Vitamine D et insuffisance rénale chronique : regain d'intérêt pour une vitamine oubliée, Rev. Méd. Suisse, pp.2140-2145, 2012.

F. Tokmak, High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients, Nephrology Dialysis Transplantation, vol.23, issue.12, pp.4016-4020, 2008.
DOI : 10.1093/ndt/gfn367

M. F. Holick, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.7, pp.1911-1930, 2011.
DOI : 10.1210/jc.2011-0385

D. Prié and P. Urena, Le rôle joué par l'axe FGF23-Klotho dans la régulation rénale de l'homéostasie du phosphate, 2008.

M. J. Bolland, Randomised controlled trial of vitamin D supplementation in sarcoidosis, BMJ Open, vol.3, issue.10, p.3562, 2013.
DOI : 10.1136/bmjopen-2013-003562

J. A. Alvarez, High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial, American Journal of Clinical Nutrition, vol.96, issue.3
DOI : 10.3945/ajcn.112.040642

P. Marckmann, Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D, Nephrology Dialysis Transplantation, vol.27, issue.9, pp.3523-3531, 2012.
DOI : 10.1093/ndt/gfs138

P. Chandra, ) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study, Endocrine Practice, vol.14, issue.1, pp.10-17, 2008.
DOI : 10.4158/EP.14.1.10

L. Xu, Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials, PLoS ONE, vol.147, issue.(Suppl 85), p.61387, 2013.
DOI : 10.1371/journal.pone.0061387.s007

C. Battista, Over-supplementation of vitamin D in two patients with primary hyperparathyroidism, HORMONES, vol.12, issue.4, pp.598-601, 2013.
DOI : 10.14310/horm.2002.1449

K. Ng, Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial, American Journal of Clinical Nutrition, vol.99, issue.3, pp.587-598, 2014.
DOI : 10.3945/ajcn.113.067777

L. Yang, Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn???s Patients, Clinical and Translational Gastroenterology, vol.10, issue.4, p.33, 2013.
DOI : 10.1038/ctg.2013.1

N. J. Bosomworth, Atténuer la carence épidémique en vitamine D, Can. Fam. Physician, vol.57, pp.1-6, 2011.

G. Jean, J. Souberbielle, S. Lechevallier, and C. Chazot, Kinetics of serum 25-hydroxyvitamin D in haemodialysis patients treated with monthly oral cholecalciferol, Clinical Kidney Journal, vol.8, issue.4, pp.388-392, 2015.
DOI : 10.1093/ckj/sfv052

P. Delanaye, Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study, Nephrology Dialysis Transplantation, vol.28, issue.7, pp.1779-1786, 2013.
DOI : 10.1093/ndt/gft001

A. M. Guignon, F. Grain, and B. Allenet, Evaluation de l'impact clinique des opinions pharmaceutiques dans un service de médecine spécialisée, pp.118-123, 2001.